進入過Phase 3,但失敗了.

In practice, Zadaxin has failed multiple Phase III FDA studies for various indications of effect. It should therefore come as no surprise that SCLN has not been able to win approval for sale of Zadaxin in the U.S. Furthermore, Zadaxin is not approved for sale in Europe. These circumstances exist despite a 10+ year marketing/distribution collaboration with and $3.7 million funding from Italian distributor Sigma-Tau.

SciClone Pharmaceuticals, Inc. (SCLN): SciClone's Strategic Partner ...

所有跟帖： 

• 回複：進入過Phase 3,但失敗了. -天天逛城- ♀ (167 bytes) () 12/08/2013 postreply 19:18:50